Invited Speaker
37th TROG Cancer Research Annual Scientific Meeting 2025
Days
Tuesday, 18th March
Wednesday, 19th March
Thursday, 20th March
Friday, 21st March
Search
Speakers
NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).
(#5)
Michael Huo
1
Queensland Health, Woolloongabba, QLD, Australia
Content is not available at the time of publishing.